Dabrafenib
ATC L01EC02 · 11 markets · 35 records
US 4 records · 3 strengths
GB 4 records · 3 strengths
- 75 mgcapsuleTafinlar
- 50 mgcapsuleTafinlar
- 10 mgtabletFinlee 10mg dispersible tablets
CN 4 records · 2 strengths
HK 4 records · 1 strengths
4 records · 0 manufacturers 4 registros · 0 fabricantes 4 个记录 · 0 个厂家 4 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
CA 3 records · 3 strengths
AU 3 records · 3 strengths
SG 3 records · 3 strengths
- 75 mgcapsuleTAFINLAR HARD CAPSULE 50MG
- 50 mgcapsuleTAFINLAR HARD CAPSULE 50MG
- 10 mgtabletTafinlar
ES 3 records · 3 strengths
- 75 mgcapsuleTafinlar
- 50 mgcapsuleTafinlar
- 10 mgtabletFINLEE DISPERSABLES
FR 3 records · 3 strengths
- 88.88 mgcapsuleTAFINLAR 50 mg, gélule
- 59.25 mgcapsuleTAFINLAR 50 mg, gélule
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
TW 2 records · 2 strengths
EU 2 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK | EU | FR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 75 mg capsule | Tafinlar | Tafinlar | Tafinlar | Tafinlar | TAFINLAR HARD CAPSULE 50MG | 泰菲乐甲磺酸达拉非尼 | Tafinlar | Tafinlar 泰伏樂膠囊75毫克 | |||
| 50 mg capsule | Tafinlar | Tafinlar | Tafinlar | Tafinlar | TAFINLAR HARD CAPSULE 50MG | 泰菲乐甲磺酸达拉非尼 | Tafinlar | Tafinlar 泰伏樂膠囊50毫克 | |||
| 10 mg tablet | Manufacturer: Novartis Pharma Stein AG Tafinlar | Finlee 10mg dispersible tablets | Tafinlar | Tafinlar | Tafinlar | FINLEE DISPERSABLES | |||||
| 88.88 mg capsule | TAFINLAR 50 mg, gélule | ||||||||||
| 59.25 mg capsule | TAFINLAR 50 mg, gélule | ||||||||||
unknown | Tafinlar | Finlee 10mg dispersible tablets Tafinlar | |||||||||
tablet | FINLEE 10 mg, comprimé dispersible |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
4 more strength/form rows are recorded only in HK · EU · FR and are not shown in this table. Hay 4 filas de concentración/forma registradas solo en HK · EU · FR que no se muestran en esta tabla. 另有 4 个规格/剂型仅在 HK · EU · FR 有记录(未在本表显示)。 另有 4 個規格/劑型僅在 HK · EU · FR 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Also called: 达拉菲尼 nickname
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.